[go: up one dir, main page]

TR200102245T2 - Method for preventing or reducing cardiovascular events related to coronary intervention. - Google Patents

Method for preventing or reducing cardiovascular events related to coronary intervention.

Info

Publication number
TR200102245T2
TR200102245T2 TR2001/02245T TR200102245T TR200102245T2 TR 200102245 T2 TR200102245 T2 TR 200102245T2 TR 2001/02245 T TR2001/02245 T TR 2001/02245T TR 200102245 T TR200102245 T TR 200102245T TR 200102245 T2 TR200102245 T2 TR 200102245T2
Authority
TR
Turkey
Prior art keywords
preventing
events related
cardiovascular events
coronary intervention
reducing cardiovascular
Prior art date
Application number
TR2001/02245T
Other languages
Turkish (tr)
Inventor
R. Granett Jeffrey
H. Shusterman Neil
C. U'prichard David
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200102245T2 publication Critical patent/TR200102245T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bir memelide koroner müdahale ile ilgili kardiyovasküler olaylarin önlenmesi veya azaltilmasi için 300 mg ila 1200 mg günlük dozda N-(3',4'-dimetoksikinnamoil)anthranilik asid (N-5') veya farmasötik olarak kabul edilir tuzunun verilmesini içeren bir yöntem.A method of preventing or reducing cardiovascular events related to coronary intervention in a mammal, comprising administering N- (3 ', 4'-dimethoxyquinamoyl) anthranilic acid (N-5') or pharmaceutically acceptable salt in a daily dose of 300 mg to 1200 mg.

TR2001/02245T 1999-02-03 2000-02-02 Method for preventing or reducing cardiovascular events related to coronary intervention. TR200102245T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11846299P 1999-02-03 1999-02-03

Publications (1)

Publication Number Publication Date
TR200102245T2 true TR200102245T2 (en) 2002-05-21

Family

ID=22378750

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02245T TR200102245T2 (en) 1999-02-03 2000-02-02 Method for preventing or reducing cardiovascular events related to coronary intervention.

Country Status (17)

Country Link
EP (1) EP1171116A4 (en)
JP (1) JP2002536327A (en)
KR (1) KR20010101934A (en)
CN (1) CN1345237A (en)
AU (1) AU2636600A (en)
BR (1) BR0007921A (en)
CA (1) CA2361581A1 (en)
CO (1) CO5150206A1 (en)
HK (1) HK1045104A1 (en)
HU (1) HUP0200129A3 (en)
IL (1) IL144721A0 (en)
MX (1) MXPA01007835A (en)
NO (1) NO20013788L (en)
PL (1) PL351397A1 (en)
TR (1) TR200102245T2 (en)
WO (1) WO2000045811A1 (en)
ZA (1) ZA200106353B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (en) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 Preventive and therapeutic agent for intimal cell hyperproliferative disease
CA2153553A1 (en) * 1994-07-13 1996-01-14 Hidekazu Suzuki Stable lipid emulsion
CA2231465A1 (en) * 1995-09-07 1997-03-13 Kissei Pharmaceutical Co., Ltd. 2-acylaminobenzamide derivatives and an agent for the prevention and treatment of diseases caused by excessive proliferation of vascular intimal cells
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention

Also Published As

Publication number Publication date
MXPA01007835A (en) 2002-04-24
CA2361581A1 (en) 2000-08-10
HUP0200129A3 (en) 2003-06-30
HK1045104A1 (en) 2002-11-15
ZA200106353B (en) 2002-08-02
BR0007921A (en) 2002-09-10
PL351397A1 (en) 2003-04-07
HUP0200129A2 (en) 2002-05-29
CN1345237A (en) 2002-04-17
EP1171116A1 (en) 2002-01-16
WO2000045811A1 (en) 2000-08-10
CO5150206A1 (en) 2002-04-29
NO20013788L (en) 2001-09-28
KR20010101934A (en) 2001-11-15
JP2002536327A (en) 2002-10-29
AU2636600A (en) 2000-08-25
IL144721A0 (en) 2002-06-30
EP1171116A4 (en) 2004-11-17
NO20013788D0 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
BR9510168A (en) Polyamino acid compound composition unit dosage form and method for preparing a composition
JP2002531505A5 (en)
MY115662A (en) Novel compounds with analgesic effect
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
ATE424810T1 (en) A DELAYED-RELEASE TABLET CONTAINING A HYDROCOLLOID AND A CELLULOSE ETHER
KR930003912A (en) Congestive Heart Failure Treatment Cure
EA200200106A1 (en) PHARMACEUTICAL COMPOSITION OF LEVODOPA / CARBIDOPE / ENTACAPON
FI973163A0 (en) Treatment of incontinence using (S) -oxybutynin and (S) -desethyloxybutynin
TR200201668T2 (en) Peptide-free inhibitors of cell binding due to Vla-4
ATE260658T1 (en) PHARMACEUTICAL PREPARATIONS FOR REDUCING RESPIRATORY DEPRESSION
TR200103613T2 (en) Pharmaceutical formulations and methods containing morphine administered intranasally.
YU32196A (en) Application of compound for preparation of medicine useful for inhibiting vascular smooth muscle cell migration
DE69637050D1 (en) USE OF N-SUBSTITUTED PYRIDONES AS TUMOR NECROSIS FACTOR ALPHA HEMMER
AR012853A1 (en) TRANSPARENT INJECTABLE FORMULATION OF ANESTHETIC COMPOUND
FI925801A0 (en) PIPERIDYL SUBSTITUERADE INDOLER
NO20003313L (en) Therapeutic agents
EA200100947A1 (en) CHEWING TABLETS WITH HIGH N-ACETYLCECHETINE CONTENT
EA199901116A1 (en) COMPOSITION INCLUDING 5- [4- [2- (N-METHYL-N-2-Pyridyl) -AMINO) ETOXY] BENZYL] TIAZOLIDIN-2,4-DION
FI934680A0 (en) ARYLMORFOLIN, FRAMSTAELLNING OCH ANVAENDING
TR199801184T2 (en) New compounds with analgesic action.
TR200102245T2 (en) Method for preventing or reducing cardiovascular events related to coronary intervention.
TR200102087T2 (en) New morpholinbenzamide salts
GEP20043231B (en) Resorcinol Composition
TR200102262T2 (en) Method for preventing or reducing cardiovascular events related to coronary intervention.
TR200103704T2 (en) Therapeutic agents